euportal twitter euportal facebook

BioNTech-Pfizer four million more doses of COVID-19 vaccines

COVID - 19 2

10.3.2021 – The European Commission has reached an agreement with BioNTech-Pfizer for the supply of four million more doses of COVID-19 vaccines for Member States in the next two weeks in order to tackle coronavirus hotspots and to facilitate free border movement.The Commission is following closely the evolution of the epidemiological situation in Member States. [...]

Read more

COVID -19 vaccine: Statement by von der Leyen on Moderna

COVID -19

24.11.2020 – “This contract allows us to buy up to 160 million doses of a vaccine produced by Moderna. According to the results of clinical trials, this vaccine could be highly effective against COVID-19. Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on [...]

Read more

Research project support

COVID - 19 2

11.9.2020 – The Commission announced today that it will support with €4 million a new research project, SUPPORT-E, that will coordinate efforts to determine if COVID-19 convalescent plasma transfusion – using plasma from patients who recovered from the disease – is an effective and safe treatment. The funding is part of the Commission’s €1 billion [...]

Read more

Commission and EIB provide loan for CureVac for vaccine development

COVID -19

6.7.2020 – The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a €75 million loan agreement to support the Company’s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. In addition, the [...]

Read more